Tumor-Targeting gene therapy and regeneration of injured lung by mssenchymal stem cells
Tumor-Targeting gene therapy and regeneration of injured lung by mssenchymal stem cells
批准号:
16390232
负责人:
SAIJO Yasuo
金额:
$9.28万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (B)
财政年份:
2004
资助国家:
日本
项目状态:
已结题
起止时间:
2004 至 2006
中文摘要
1.通过表达CX 3CL 1或NK的间充质干细胞(MSC)靶向基因治疗多发性肺转移瘤41)通过表达CX 3CL 1的MSC治疗肺转移瘤通过经尾静脉注射B16或C26细胞制备肺转移瘤模型。用AdRGDCX 3CL 1离体感染MSC(MSC/CX 3CL 1)。将MSC/CX 3CL 1静脉注射到具有肺转移的小鼠中。这种治疗通过诱导先天性和过继性免疫抑制肺转移的发展。小鼠的存活时间也通过这种治疗延长。2)表达NK 4的MSC治疗肺转移瘤NK 4是一种针对HGF的拮抗剂,HGF诱导肿瘤血管生成、生长和转移。用AdRGDNK 4离体感染MSC(MSC/NK 4)。将MSC/NK 4静脉注射至具有肺转移的小鼠。这种治疗通过抑制血管生成来抑制肺转移的发展。这种治疗也延长了小鼠的存活时间。1)博莱霉素对肺损伤的评价将博莱霉素注入肺内,诱导肺损伤。通过测定Ashicroft评分和羟脯氨酸含量,建立肺损伤的评价方法。2)肺损伤的MSCs治疗方法肺内注射博莱霉素诱导肺损伤。骨髓间充质干细胞静脉注射到用博来霉素预处理的小鼠中。用AdRGDHGF感染MSCs,诱导MSCs分泌HGF。AdRGDHGF感染MSCs后可大量分泌HGF
英文摘要
1.Targeted gene therapy for multiple lung metastases by mesenchymal stem cells (MSCs) expressing CX3CL1 or NK41)Treatment of lung metastases by MSCs expressing CX3CL1Lung metastases models were made by injection of B16 or C26 cells via tail vain. MSCs were infected with AdRGDCX3CL1 ex vivo (MSCs/CX3CL1). The MSCs/CX3CL1 were injected intravenously to the mice with lung metastases. This treatment inhibited development of lung metastases by inducing innate and adoptive immunity. The survival of mice also was prolonged by this treatment. This study is in press in Stem Cells.2)Treatment of lung metastases by MSCs expressing NK4NK4 is an antagonist against HGF which induces tumor angiogenesis, growth, and metastases. MSCs were infected with AdRGDNK4 ex vivo (MSCs/NK4). The MSCs/NK4 were injected intravenously to the mice with lung metastases. This treatment inhibited development of lung metastases by inhibiting angiogenesis The survival of mice also was prolonged by this treatment. This study is in press in Cancer Gene Therpay.2.Treatment of injured lung by MSCs expressing HGF1)Evaluation of lung injury by bleomycinBleomycin was injected intratracheally to the lung to induce lung injury. Methods of lung injury evaluation were established by measuring Ashicroft score and hydroxyproline contents.2)Treatment of injured lung by MSCsBleomycin was injected intratracheally to the lung to induce lung injury. MSCs were intravenously injected to the mice pretreated with bleomycin. Treatment of MSCs improved lung injury.HGF secretion from MSCs infected with AdRGDHGFAdRGDHGF was made. MSCs infected with AdRGDHGF secreted large amount of HGF
期刊论文(33)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
Vaccination of dendritic cells loaded with interleukin-12-secreting cancer cells augments in vivo antitumor immunity :
接种负载有白细胞介素 12 分泌癌细胞的树突状细胞可增强体内抗肿瘤免疫力:
DOI:
--
发表时间:
2005
期刊:
Clinical Cancer Research 11
影响因子:
--
作者:
[Suzuki T, Saijo Y et al.]
通讯作者:
Saijo Y et al.
Infiltration of COX-2-expressing macrophages is a prerequisite for IL-1 beta-induced neovascularization.
表达 COX-2 的巨噬细胞的浸润是 IL-1 β 诱导的新血管形成的先决条件。
DOI:
--
发表时间:
2005
期刊:
J Clin Invest 115
影响因子:
--
作者:
[Inoue A, Usui K, Kanbe M, Gomi K, Koinumaru S, Saijo Y, Nukiwa T., Nakao S, Kikuchi T, Xin H, Suzuki T, Nakao S]
通讯作者:
Nakao S
Involvement of Fractalkine/CX3CL1 expression by dendritic immunity against Legionella peumophilia cells in the enhancement of host
Fractalkine/CX3CL1 表达通过针对嗜肺军团菌细胞的树突状免疫增强宿主
DOI:
--
发表时间:
2005
期刊:
Infect Immun 73
影响因子:
--
作者:
[Inoue A, Usui K, Kanbe M, Gomi K, Koinumaru S, Saijo Y, Nukiwa T., Nakao S, Kikuchi T, Xin H, Suzuki T, Nakao S, Kikuchi T]
通讯作者:
Kikuchi T
Antitumor Immune Response by CX3CL1 Fractalkine Gene Transfer Depends on both NK and Cells
CX3CL1 Fractalkine 基因转移的抗肿瘤免疫反应取决于 NK 和细胞
DOI:
--
发表时间:
2005
期刊:
European Journal of Immunology (In press)
影响因子:
--
作者:
[Xin H, Saijo Y et al.]
通讯作者:
Saijo Y et al.
Phase I/II study of carboplatin combined with biweekly docetaxel for advanced non-small cell lung cancer
卡铂联合双周多西他赛治疗晚期非小细胞肺癌的I/II期研究
DOI:
--
发表时间:
2006
期刊:
J Thorac Oncol 1
影响因子:
--
作者:
[Takeshita K, et al., Ishimoto O]
通讯作者:
Ishimoto O
共 23 条
a study and new treatment of lung cancer stem cells
-
批准号:20390229
-
项目类别:Grant-in-Aid for Scientific Research (B)
-
资助金额:$11.81万
-
财政年份:2008
-
负责人:SAIJO Yasuo
-
依托单位:
Immuno-gene therapy for non-small lecclung cancer using innate immunity by NKG2D and its ligand.
-
批准号:13670588
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.3万
-
财政年份:2001
-
负责人:SAIJO Yasuo
-
依托单位:
Tumor promotion effect by IL-1β gene transfer : Analysis of cancer-stromal interaction.
-
批准号:11670563
-
项目类别:Grant-in-Aid for Scientific Research (C)
-
资助金额:$2.18万
-
财政年份:1999
-
负责人:SAIJO Yasuo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
CX3CL1/CX3CR1轴控制小胶质细胞炎症反应减轻七氟烷吸入麻醉药对发育期大脑神经毒性及机制研究
-
批准号:JCZRLH202600615
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
钩藤降压解郁方通过P2X7R和CX3CL1双信号调控小胶质细胞极化抑制p38MAPK途径改善高血压并发抑郁症海马神经元损伤的机制研究
-
批准号:2025JJ80071
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:任卫琼
-
依托单位:
TGF- β1调控CX3CL1/CX3CR1信号通路对肺纤维化的作用机制研究
-
批准号:2025JJ80717
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:罗曼
-
依托单位:
间歇低氧通过CX3CL1/CX3CR1/mTOR抑制衰老肝细胞清除参与MAFLD的机制研究
-
批准号:2025JJ50713
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:李亚勇
-
依托单位:
ACSL4通过CX3CL1激活小胶质细胞调控海马神经元铁死亡介导抑郁症的作用机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:向涯洁
-
依托单位:
CX3CL1/CX3CR1介导结肠-膀胱交叉敏感化在慢性精神应激后间质性膀胱炎疼痛中的作用研究
-
批准号:2025JJ50607
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:高云亮
-
依托单位:
益肾壮筋合剂通过上调Hmga1并抑制Cx3cl1介导 WNT及P13K/AKT维持骨稳态的干预机制
-
批准号:
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2024
-
负责人:陆苇
-
依托单位:
针刺通过CX3CL1/CX3CR1轴调控FMS胶质细胞-神经元串扰缓解中枢敏化的抗炎镇痛机制
-
批准号:82374202
-
项目类别:面上项目
-
资助金额:49万元
-
批准年份:2023
-
负责人:阚宇
-
依托单位:
人脐带间充质干细胞通过CX3CL1趋化因子调控孤独症谱系障碍大鼠突触可塑性的机制研究
-
批准号:2023JJ30439
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:张依蕾
-
依托单位:
组蛋白乙酰化修饰lncRNA-XIST/miR-122-5p/CX3CL1轴介导的肾小球局部免疫反应在特发性膜性肾病发病中的机制研究
-
批准号:82360145
-
项目类别:地区科学基金项目
-
资助金额:32万元
-
批准年份:2023
-
负责人:柯本
-
依托单位: